BioSpace News Archive

Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on next-generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, today announced that it has submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to eval

The Hairy Cell Leukemia Foundation (HCLF) and The Leukemia & Lymphoma Society (LLS) announced today they are teaming up to support a research grants program of up to $10 million over five years, to build a more comprehensive understanding of hairy cell leukemia (HCL), develop better therapies and optimize outcom

Rallybio, a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders, today announced that it has appointed Paula Soteropoulos to its Board of Directors. Ms. Soteropoulos is an accomplished biopharmaceutical industry leader with more than 30 years of rare disease experience in strategic and operational leadership areas i

Today, the Cystic Fibrosis Foundation announced a new research award of up to $2.4 million to Calithera Biosciences Inc. to advance a potential treatment to reduce infections in the lungs of people with cystic fibrosis. Individuals with CF who have chronic infections are at greater risk for worsening, life-threatening lung disease,

Nortech Systems Incorporated (Nasdaq: NSYS), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical, aerospace & defense and industrial markets, named Christopher D. Jones as Chief Financial Officer and Senior Vice President of Finance effective today. “We are very pleased that Chris has joined Nortech’s team as the leader of the

Other headline speakers include Dr. Jeffrey Shuren, director of the Center for Devices and Radiological Health (CDHR) at the Food and Drug Administration (FDA); Dr. Peter Marks, director of the Center for Biologics Evaluation and Research (CBER) at the FDA; and more.

Public Procurement Service and Korea Health Industry Development Institute will host ' K-Quarantine Online Procurement Expo ' in a virtual space from November 9th to 13th for five days. This press release features multimedia. View the full release here: https://www.bus

TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company, and Augmenta Bioworks, Inc., a biotechnology company enabling breakthroughs in medicine through immune profiling, today jointly announce that both companies have entered into a worldwide Joint

Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology based therapies for prevalent inflammatory conditions, announced today that the Company will present a business and f

Hygea Precision Medicine, a company focused on developing a precision medicine software system for healthcare providers and patients to effectively manage genetic testing, announced today that it has partnered with 1health.io, the leading Testing as a Service (TaaS) company.